Core Viewpoint - The personal care products sector experienced a decline of 1.72% on January 15, with a notable drop in the stock of Wanjian Medical, while the overall market showed mixed results with the Shanghai Composite Index down 0.33% and the Shenzhen Component Index up 0.41% [1] Group 1: Market Performance - The personal care products sector's decline was led by Wanjian Medical, which fell by 3.57% to a closing price of 38.08 [2] - The Shanghai Composite Index closed at 4112.6, down 0.33%, while the Shenzhen Component Index closed at 14306.73, up 0.41% [1] Group 2: Individual Stock Performance - Notable stock performances included: - Dengkang Oral (001328) rose by 2.51% to 41.27 with a trading volume of 28,300 shares and a transaction value of 116 million [1] - Other stocks such as Zhongshun Jierou (002511) and Liangmian Needle (600249) saw minor declines of 0.24% and 0.51% respectively [1] - The largest decline was observed in Wanjian Medical (300888), which dropped by 3.57% [2] Group 3: Capital Flow - The personal care products sector saw a net inflow of 531,700 yuan from institutional investors, while retail investors experienced a net outflow of 2,407,430 yuan [2] - The capital flow for individual stocks indicated that Wanjian Medical had a net inflow of 21,931,300 yuan from institutional investors, but a significant outflow of 45,204,800 yuan from retail investors [3]

Core Viewpoint - The personal care products sector experienced a slight increase of 0.2% on January 14, with Baiya Co., Ltd. leading the gains, while the Shanghai Composite Index fell by 0.31% and the Shenzhen Component Index rose by 0.56% [1]. Group 1: Market Performance - The closing price of Baiya Co., Ltd. was 21.24, with an increase of 1.09% and a trading volume of 77,000 shares, amounting to a transaction value of 163 million yuan [1]. - Other notable performers included Yiyi Co., Ltd. with a closing price of 28.72 and a rise of 1.06%, and Haoyue Care with a closing price of 32.78 and an increase of 1.02% [1]. - Conversely, companies like Jiya Co., Ltd. and Wanjian Medical saw slight declines of 0.19% and 0.23%, respectively [1]. Group 2: Capital Flow - The personal care products sector saw a net inflow of 4.32 million yuan from institutional investors, while retail investors experienced a net outflow of 7.12 million yuan [2]. - The capital flow data indicates that Yiyi Co., Ltd. had a significant net inflow of 13.31 million yuan from institutional investors, while it faced a net outflow of 6.19 million yuan from retail investors [3]. - Other companies like Haoyue Care and Dongkang Oral also showed mixed capital flows, with institutional inflows but retail outflows [3].

Core Viewpoint - The company, Runben Biotechnology Co., Ltd., has successfully passed the re-certification as a high-tech enterprise, which will allow it to continue enjoying tax benefits for the next three years [1]. Group 1: Certification Details - The company received its high-tech enterprise certification from the National High-tech Enterprise Recognition Management Work Leading Group Office, with certificate number GR202544006259, issued on December 19, 2025, and valid for three years [1]. - This re-certification follows the expiration of the company's previous high-tech enterprise certificate [1]. Group 2: Tax Benefits - As a result of the high-tech enterprise recognition, the company will benefit from a reduced corporate income tax rate of 15% for three consecutive years, from 2025 to 2027 [1]. Group 3: Implications for the Company - The recognition as a high-tech enterprise is a significant affirmation of the company's technological innovation and independent research and development capabilities [1]. - This status is expected to enhance the company's overall competitiveness and support its sustainable development [1].

Group 1 - The company, Runben Co., has recently been recognized as a high-tech enterprise by the National High-tech Enterprise Recognition Management Work Leading Group Office [2] - The certificate number for the high-tech enterprise recognition is GR202544006259, with an issuance date of December 19, 2025, and a validity period of three years [2] - This recognition is a re-evaluation following the expiration of the company's previous high-tech enterprise certificate [2]

Market Overview - The personal care products sector experienced a slight decline of 0.03% on January 13, with Baiya Co., Ltd. leading the drop [1] - The Shanghai Composite Index closed at 4138.76, down 0.64%, while the Shenzhen Component Index closed at 14169.4, down 1.37% [1] Stock Performance - Notable gainers in the personal care sector included: - Dengkang Oral Care (001328) with a closing price of 40.60, up 6.17% [1] - Beijia Clean (603059) with a closing price of 36.25, up 3.93% [1] - Jieya Co., Ltd. (301108) with a closing price of 35.95, up 3.72% [1] - Other stocks showed mixed performance, with some experiencing declines, such as: - Two-Sided Needle (600249) down 0.67% to 5.92 [1] - Zhongshun Jiesang (002511) down 0.95% to 8.32 [1] Capital Flow - The personal care products sector saw a net inflow of 17.19 million yuan from institutional investors, while retail investors experienced a net outflow of 20.21 million yuan [2] - The capital flow for individual stocks indicated that: - Reliable Co., Ltd. (301009) had a net inflow of 10.73 million yuan from institutional investors [3] - Beijia Clean (603059) faced a net outflow of 3.99 million yuan from institutional investors [3]

Core Viewpoint - Runben Co., Ltd. has been recognized as a high-tech enterprise by the National High-tech Enterprise Recognition Management Work Leading Group Office, with a certificate number GR202544006259, valid for three years starting from December 19, 2025 [1] Group 1 - The company has successfully passed the high-tech enterprise recognition process, which is a renewal of its previous high-tech enterprise certificate that has expired [1]

证券代码：603193 证券简称：润本股份 公告编号 2026-001 润本生物技术股份有限公司 润本生物技术股份有限公司（以下简称"公司"）于近日从全国高新技术企业 认定管理工作领导小组办公室发布的《对广东省认定机构 2025 年认定报备的第二 批高新技术企业进行备案的公告》获悉，公司已通过高新技术企业认定，证书编号 为 GR202544006259，发证日期为 2025 年 12 月 19 日，有效期三年。 本次高新技术企业的认定系公司原高新技术企业证书有效期满后进行的重新认 定。根据《中华人民共和国企业所得税法》等有关规定，公司自本次通过高新技术 企业认定后连续三年（2025 年至 2027 年），可继续享受国家关于高新技术企业的 税收优惠政策，即按 15%的税率缴纳企业所得税。 高新技术企业的认定，是对公司技术创新及自主研发能力的充分肯定，有助于 提升公司的综合竞争力，有利于公司可持续发展。 关于公司通过高新技术企业重新认定的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 特此公告。 润本生物技术股份有限公司董事 ...

Market Overview - The personal care products sector increased by 1.28% on January 12, with Beijia leading the gains [1] - The Shanghai Composite Index closed at 4165.29, up by 1.09%, while the Shenzhen Component Index closed at 14366.91, up by 1.75% [1] Stock Performance - Beijia (603059) closed at 34.88, with a rise of 10.00% and a trading volume of 21,500 lots, resulting in a transaction value of 74.26 million yuan [1] - Haoyue Care (605009) closed at 32.52, up by 2.59%, with a trading volume of 38,600 lots and a transaction value of 124 million yuan [1] - Reliable Co. (301009) closed at 13.11, increasing by 1.55%, with a trading volume of 47,100 lots and a transaction value of 61.36 million yuan [1] - Other notable stocks include: - Wenjian Medical (300888) at 39.73, up by 1.43% [1] - Runben Co. (603193) at 25.33, up by 1.40% [1] - Liangmian Needle (600249) at 5.96, up by 1.36% [1] Capital Flow - The personal care products sector experienced a net outflow of 1.1334 million yuan from institutional investors, while retail investors saw a net inflow of 5.4803 million yuan [2] - The overall capital flow indicates that while institutional investors withdrew funds, retail investors were actively buying into the sector [2] Detailed Capital Flow Analysis - Beijia (603059) had a net inflow of 23.84 million yuan from institutional investors, but a net outflow of 9.50 million yuan from speculative funds [3] - Haoyue Care (605009) saw a net inflow of 18.45 million yuan from institutional investors, with a net outflow of 12.29 million yuan from speculative funds [3] - Reliable Co. (301009) experienced a net outflow of 5.92 million yuan from institutional investors, while retail investors contributed a net inflow of 6.46 million yuan [3]

Group 1 - The report maintains a positive outlook on the beauty and personal care industry, highlighting the ongoing trend of domestic substitution and the emergence of high-quality domestic brands [1][5] - The beauty and personal care sector is expected to continue its growth trajectory, driven by strong brand marketing, product matrix, channel strategies, and management strategies [5][27] - The report identifies key investment opportunities in leading domestic brands such as Mao Ge Ping, Marubi, Proya, and RuYuchen, which are expected to maintain strong growth due to their competitive advantages [5][27] Group 2 - In 2025, the beauty and personal care sector showed stable revenue performance, with a slight increase in profit growth compared to revenue growth [17][22] - The overall performance of the beauty sector in 2025 was moderate, with a year-on-year revenue increase of 3.1% and a net profit increase of 5.0% [17][22] - The cosmetics market in 2025 experienced a steady retail growth rate, with a year-on-year increase of 4.8% in retail sales for cosmetics in China [22][27] Group 3 - The report notes a significant shift in consumer preferences towards efficacy-driven skincare products, with a growing focus on product ingredients and effectiveness [53][57] - The luxury segment of the beauty market is experiencing robust growth, particularly during promotional events, with high-end brands leading the sales increase [63][64] - The report highlights the transformation of sales channels, with Tmall focusing on high-end beauty products while Douyin showcases the rise of domestic brands [30][28] Group 4 - The medical aesthetics market is projected to maintain a compound annual growth rate (CAGR) of around 10% from 2025 to 2028, despite a slowdown in overall growth [31][38] - High-end consumers are increasingly seeking anti-aging treatments, with a notable rise in spending among this demographic [41][39] - The medical aesthetics industry is undergoing a consolidation phase, driven by stricter regulations and a slowdown in the growth of medical institutions [42][43] Group 5 - The personal care market is seeing strong growth in body care products, with a market share of 56% for body care and 44% for hair care [47][45] - The primary consumer demographic for personal care products is women aged 21-35, indicating a growing emphasis on personal care among younger consumers [48][49] - The report emphasizes the importance of product efficacy, with consumers increasingly prioritizing moisturizing, oil control, and beauty-enhancing benefits in personal care products [48][50]

Core Viewpoint - The light industry and beauty care sector is expected to stabilize and improve by 2026, driven by domestic demand policies and steady export growth, despite facing certain pressures in the broader environment [2] Domestic Demand - The "14th Five-Year Plan" year is anticipated to see an increase in domestic demand policies, coupled with a growing consumer pursuit of high-quality living, which opens up significant growth opportunities for the industry [2][3] Export Potential - The cross-border e-commerce penetration rate has substantial room for improvement, and the improvement of international relations along with the demand boost from emerging markets will further expand the market, injecting momentum into the industry's overseas expansion [2][3] Company Insights - Companies with core technology and brand advantages are expected to seize opportunities, with cutting-edge technology enhancing product competitiveness and brand strength breaking the price-performance competition [2] - These companies are likely to benefit from domestic demand and explore overseas markets through global layouts, leading the growth in the trend of high-quality industry development [2] Investment Focus - **Beauty Sector**: Focus on high-end skincare and makeup brands with Eastern cultural characteristics such as Maogeping (01318) and Lin Qingxuan (02657), as well as companies like Marubi Biotechnology (603983.SH) showing marginal improvements [3] - **Home Furnishing**: Attention on leading companies with strong channel capabilities and multi-category layouts like Oppein Home Group (603833.SH) and Kuka Home (603816.SH), as well as Man Wah Holdings (01999) benefiting from the anticipated recovery in the US real estate market due to Federal Reserve rate cuts [3] - **Two-Wheel & Motorcycle**: The two-wheeler market is generally stable with a natural replacement cycle, and companies like Yadea Technology (01585), Aima Technology (603529.SH), and Ninebot (689009.SH) are under focus as market expectations are currently pessimistic [3] Light Industry Consumption - **Personal Care**: Companies with a big product strategy and all-channel expansion capabilities such as Baiya Co., Ltd. (003006.SZ) and Weigao Medical (300888.SZ) are noteworthy [4] - **Stationery**: Product and channel optimization are key for stationery companies adapting to current consumer trends, with attention on Morning Glory (603899.SH) and Qixin Group (002301.SZ) [4] Jewelry Sector - Focus on Laopu Gold (06181), which is expected to see performance growth due to continuous channel expansion and market breakthroughs [5] Export Companies - Companies with significant technical barriers and brand advantages in high-demand segments such as Haoyang Co., Ltd. (300833.SZ) and Yiyi Co., Ltd. (001206.SZ) are of interest [5]